Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Indrayani Biotech Ltd. (INDRANIB)
Market Open
11 Aug, 22:00
MSE
All
(1)
IN
(1)
MSE
Primary
₹
7.
89
-0.69
-8.042%
₹
344.71M
Market Cap
-
P/E Ratio
-
Div Yield
68,460
Volume
0
Eps
₹
8.58
Previous Close
Watching
Watch
Add Transaction
Day Range
7.56
8.8
Year Range
6.1
16.47
Want to track
INDRANIB
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Splits
Statistics
Historical Data
Indrayani Biotech Ltd. (INDRANIB) Statistics
Valuation metrics
Market Cap
344.71M
Enterprise value
397.08M
Trailing P/E (ttm)
-6.74
Forward P/E
-
PEG ratio
0.03
Price/Sales (ttm)
0.26
Price/Book (mrq)
0.38
Enterprise Value/Revenue
0.26
Enterprise Value/EBITDA
4.03
Overview
Shares outstanding
45.54M
Float
18.89M
Shares short
-
% Held by insiders
0.57%
% Held by institutions
-
Average volume (10 days)
58.88K
Average volume (90 days)
68.76K
Price summary
52-Week low
6.1
52-Week high
16.47
Beta
-0.94
50-Day moving average
8.37
200-Day moving average
9.41
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
3:25
Last split Date
24 Sep 2015
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
-0.04%
Operating margin
0%
Operational effectiveness
Return on assets
-0.02%
Return on equity
-0.07%
Income Statement
Revenue (ttm)
1.51B
Revenue per share (ttm)
33.08
Quarterly revenue growth (yoy)
1.02%
Gross profit (ttm)
398.59M
EBITDA
93.55M
Net income to common (ttm)
-27.91M
Diluted EPS (ttm)
-1.36
Quarterly earnings growth (yoy)
-0.67%
Balance Sheet
Total cash (mrq)
69.77M
Total cash per share (mrq)
1.53
Total debt (mrq)
1.46B
Total Debt/Equity (mrq)
1.93
Current ratio (mrq)
2.64%
Book value per share (mrq)
22.8
Cash Flow
Cash flow statement
25.06M
Levered free cash flow (LFCF)
-61.08M